Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Midazolam Injection

Approval Number

国药准字H19990027

Company江苏恩华药业股份有限公司

Registration Date

July 14, 2020

Drug Information

Generic Name

咪达唑仑注射液

Trade Name

力月西

Dosage Form

注射剂

Strength

1ml:5mg

Drug Type

化学药品

Registration Date

July 14, 2020

Company Information

Applicant Company

Company Name江苏恩华药业股份有限公司

Company Address

徐州经济技术开发区杨山路18号

Manufacturing Company

Company Name江苏恩华药业股份有限公司

Company Address

徐州高新技术产业开发区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

咪达唑仑注射液 - NMPA 批准文号 | MedPath